CrossrefInfokarte
A real-world disproportionality analysis of tirzepatide-related adverse events based on the FDA Adverse Event Reporting System (FAERS) database
Endocrine Journal · 2025 · 72 (3) · 273-283
DOI: 10.1507/endocrj.ej24-0286 ↗Abstract
Kein Abstract verfügbar.
EUVIMED